SAVANNAH, Ga.--(BUSINESS WIRE)--Health Discovery Corporation (HDC) (OTCBB:HDVY) today announced that IP Australia, the Australian patent office, has published the Notice of Acceptance of HDC’s patent application covering the use of recursive feature elimination in support vector machines (RFE-SVM) for identification of determinative genes for diagnosis, prognosis and treatment of disease. RFE-SVM is a mathematical selection/filtering process that successively eliminates the least important of many data features, then ranks each of the most significant of the relatively few features remaining for simultaneous use in classifying the data using SVMs. The most significant benefit is an increase in the accuracy and usefulness of the classification results, particularly when analyzing voluminous data, such as that encountered during the analysis of genetic and proteomic data.
